Skip to main content

Peer Review reports

From: Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p

Original Submission
31 Dec 2018 Submitted Original manuscript
16 Jan 2019 Author responded Author comments - Linhai Li
Resubmission - Version 2
16 Jan 2019 Submitted Manuscript version 2
11 Feb 2019 Reviewed Reviewer Report - Francesca Peruzzi
31 Mar 2019 Reviewed Reviewer Report - Shu-Pin Huang
20 May 2019 Author responded Author comments - Bin Xiao
Resubmission - Version 3
20 May 2019 Submitted Manuscript version 3
3 Aug 2019 Reviewed Reviewer Report - Shu-Pin Huang
9 Aug 2019 Reviewed Reviewer Report - Francesca Peruzzi
19 Aug 2019 Author responded Author comments - Bin Xiao
Resubmission - Version 4
19 Aug 2019 Submitted Manuscript version 4
Publishing
21 Aug 2019 Editorially accepted
6 Sep 2019 Article published 10.1186/s12885-019-6068-4

You can find further information about peer review here.

Back to article page